US Stock MarketDetailed Quotes
EW Edwards Lifesciences
- 59.700
- -27.250-31.34%
Close Jul 25 16:00 ET
- 59.800
- +0.100+0.17%
Post 20:02 ET
35.98BMarket Cap24.57P/E (TTM)
67.800High58.930Low45.98MVolume64.010Open86.950Pre Close2.90BTurnover7.71%Turnover Ratio25.96P/E (Static)602.60MShares96.12052wk High4.84P/B35.62BFloat Cap58.93052wk Low--Dividend TTM596.59MShs Float131.730Historical High--Div YieldTTM10.20%Amplitude1.000Historical Low63.076Avg Price1Lot Size
Edwards Lifesciences Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -9.43%1.39B | 9.50%1.6B | 11.56%6B | 13.78%1.53B | 12.27%1.48B | 11.38%1.53B | 8.83%1.46B | 2.86%5.38B | 1.40%1.35B | 0.67%1.32B |
| Operating revenue | -9.43%1.39B | 9.50%1.6B | 11.56%6B | 13.78%1.53B | 12.27%1.48B | 11.38%1.53B | 8.83%1.46B | 2.86%5.38B | 1.40%1.35B | 0.67%1.32B |
| Cost of revenue | -16.82%285.3M | 17.03%385.6M | 27.71%1.38B | 38.39%356.9M | 38.06%350.4M | 27.32%343M | 10.09%329.5M | -13.49%1.08B | -16.67%257.9M | -18.58%253.8M |
| Gross profit | -7.29%1.1B | 7.30%1.21B | 7.51%4.63B | 7.96%1.18B | 6.13%1.13B | 7.49%1.19B | 8.47%1.13B | 7.99%4.3B | 6.88%1.09B | 6.68%1.07B |
| Operating expense | -2.11%723.4M | 11.10%774.9M | 15.27%2.9B | 16.60%750M | 16.21%709.9M | 12.00%739M | 16.46%697.5M | 4.84%2.51B | -2.07%643.2M | 1.41%610.9M |
| Selling and administrative expenses | -3.82%450.8M | 12.24%489.7M | 16.39%1.82B | 16.79%480M | 16.51%439.6M | 14.60%468.7M | 17.82%436.3M | 4.95%1.57B | -3.07%411M | 3.54%377.3M |
| Research and development costs | 0.85%272.6M | 9.19%285.2M | 13.39%1.07B | 16.28%270M | 15.71%270.3M | 7.78%270.3M | 14.26%261.2M | 4.66%945.2M | -0.26%232.2M | -1.85%233.6M |
| Operating profit | -15.84%377.2M | 1.18%437.7M | -3.39%1.73B | -4.47%427.2M | -7.42%420.6M | 0.79%448.2M | -2.35%432.6M | 12.76%1.79B | 23.06%447.2M | 14.69%454.3M |
| Net non-operating interest income expense | 70.33%15.5M | 91.86%16.5M | 204.29%49.6M | 112.66%16.8M | 118.84%15.1M | 911.11%9.1M | 1,333.33%8.6M | 1,730.00%16.3M | 1,480.00%7.9M | 962.50%6.9M |
| Non-operating interest income | --15.5M | ---- | 89.30%67.2M | ---- | ---- | ---- | ---- | 104.02%35.5M | ---- | ---- |
| Non-operating interest expense | ---- | ---- | -8.33%17.6M | ---- | ---- | ---- | ---- | 4.35%19.2M | ---- | ---- |
| Total other finance cost | ---- | -91.86%-16.5M | ---- | ---- | -118.84%-15.1M | -911.11%-9.1M | ---8.6M | ---- | ---- | -962.50%-6.9M |
| Other net income (expense) | 94.87%-6.1M | -5.16%-44.8M | -372.70%-180.1M | -630.95%-22.3M | 106.68%3.6M | -721.99%-118.8M | -468.00%-42.6M | -132.79%-38.1M | -66.13%4.2M | -1,125.00%-53.9M |
| Gain on sale of security | ---- | ---- | 526.09%9.8M | ---- | ---- | 320.00%2.2M | ---- | -121.30%-2.3M | ---- | ---- |
| Special income (charges) | 93.31%-8.1M | -13.57%-50.2M | -427.10%-194.5M | -715.91%-27.1M | 95.76%-2.2M | -750.54%-121M | -952.38%-44.2M | -135.65%-36.9M | -60.00%4.4M | -794.83%-51.9M |
| -Less：Restructuring and merger&acquisition | --0 | 5,800.00%41.3M | -136.14%-9M | -71.90%17.2M | --0 | -28.71%-26.9M | 124.14%700K | 120.06%24.9M | 438.12%61.2M | -1,236.36%-12.5M |
| -Less:Other special charges | -94.52%8.1M | -79.54%8.9M | 1,595.83%203.5M | 115.09%9.9M | -96.58%2.2M | 6,330.43%147.9M | 512.68%43.5M | -41.75%12M | -1,023.94%-65.6M | 1,270.21%64.4M |
| Other non- operating income (expenses) | --2M | 237.50%5.4M | 318.18%4.6M | -338.10%-5M | 390.00%5.8M | ---- | 1,500.00%1.6M | -42.11%1.1M | 600.00%2.1M | -1,100.00%-2M |
| Income before tax | 14.21%386.6M | 2.71%409.4M | -9.58%1.6B | -8.19%421.7M | 7.86%439.3M | -27.16%338.5M | -8.60%398.6M | 3.84%1.77B | 22.06%459.3M | 4.20%407.3M |
| Income tax | -38.79%20.2M | 0.52%58.4M | -19.06%198.7M | -14.61%52M | -12.85%55.6M | -43.40%33M | -7.04%58.1M | 23.43%245.5M | 48.54%60.9M | 25.59%63.8M |
| Net income | 19.48%365M | 3.08%351M | -8.05%1.4B | -7.20%369.7M | 11.70%383.7M | -24.83%305.5M | -8.86%340.5M | 1.25%1.52B | 18.82%398.4M | 1.00%343.5M |
| Net income continuous Operations | 19.93%366.4M | 3.08%351M | -8.05%1.4B | -7.20%369.7M | 11.70%383.7M | -24.83%305.5M | -8.86%340.5M | 1.25%1.52B | 18.82%398.4M | 1.00%343.5M |
| Net income discontinuous operations | ---1.4M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Minority interest income | 18.75%-1.3M | -900K | -3M | -200K | -1.2M | -1.6M | 0 | 0 | 0 | 0 |
| Net income attributable to the parent company | 19.28%366.3M | 3.35%351.9M | -7.85%1.4B | -7.15%369.9M | 12.05%384.9M | -24.43%307.1M | -8.86%340.5M | 1.25%1.52B | 18.82%398.4M | 1.00%343.5M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 19.28%366.3M | 3.35%351.9M | -7.85%1.4B | -7.15%369.9M | 12.05%384.9M | -24.43%307.1M | -8.86%340.5M | 1.25%1.52B | 18.82%398.4M | 1.00%343.5M |
| Basic earnings per share | 19.61%0.61 | 3.57%0.58 | -6.10%2.31 | -6.15%0.61 | 14.55%0.63 | -21.54%0.51 | -6.67%0.56 | 2.07%2.46 | 20.37%0.65 | 0.00%0.55 |
| Diluted earnings per share | 22.00%0.61 | 3.57%0.58 | -5.74%2.3 | -6.15%0.61 | 14.55%0.63 | -23.08%0.5 | -5.08%0.56 | 2.52%2.44 | 22.64%0.65 | 1.85%0.55 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg